| 000 | 01009 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517111438.0 | ||
| 264 | 0 | _c20180305 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1474-5488 | ||
| 024 | 7 |
_a10.1016/S1470-2045(16)30309-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFossati, Nicola | |
| 245 | 0 | 0 |
_aTiming of androgen-deprivation therapy for prostate cancer: still a long way to go. _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _c08 2016 |
||
| 300 |
_ae313 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Comment | ||
| 650 | 0 | 4 | _aAndrogen Antagonists |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProstatic Neoplasms |
| 700 | 1 | _aGandaglia, Giorgio | |
| 700 | 1 | _aDell'Oglio, Paolo | |
| 700 | 1 | _aMontorsi, Francesco | |
| 700 | 1 | _aBriganti, Alberto | |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 17 _gno. 8 _gp. e313 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(16)30309-6 _zAvailable from publisher's website |
| 999 |
_c26315926 _d26315926 |
||